Compare Aurora Cannabis Inc (ACB) vs US Bancorp (USB) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

U.S. Bancorp (USB) trades at $62.89, up 1.88% on the day, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. The company reported 2025 net income of $7.57 billion, with a net margin of 27.04%, and maintains a solid dividend history, including a recent $0.52 per share payout. Analyst consensus is mixed but leans positive, with a price target of $66.64.

USB's outlook is supported by robust profitability and strategic partnerships, but risks include interest rate sensitivity and competitive pressures. The stock offers value with a P/E of 13.17, though investors should monitor net cash flow trends and economic conditions affecting banking sector performance.